Assessing the time-to-removal of totally implantable venous access devices comparing valved-versus open-ended catheters in patients treated with chemotherapy.

Date publication

janvier 2024

Journal

The journal of vascular access

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BOUCHE Olivier

Tous les auteurs :
Amroun K, Brugel M, Rhaiem R, Teuma L, Vannieuwenhuyse G, Lipere A, Brenet E, Kianmanesh R, Bouché O

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/38205615

Résumé

Totally IntraVenous Acess Devices (TIVAD) are used to have long-term bloodstream access. The catheter connected to the subcutaneous chamber may be valved (TIVAD-V) or open-ended (TIVAD-O). Infectious and occlusion complications require the removal of the TIVAD. We compared the two types of catheters (TIVAD-V and TIVAD-O) in terms of time-to-removal and complication rates.

Mots clés

Totally intravenous access device, chemotherapy, complications, open-ended catheter, time-to-removal, valved catheter

Référence

J Vasc Access. 2024 01 11;:11297298231223539